ZFIN ID: ZDB-FISH-150901-2423
Fish name: AB + MO3-zic2a
Genotype: AB
Targeting Reagent: MO3-zic2a
HUMAN DISEASE MODELED by AB + MO3-zic2a
No data available
GENE EXPRESSION
Gene expression in AB + MO3-zic2a
RNA expression
Expressed Gene Structure Conditions Figures
aldh1a3 standard conditions Fig. 6 with image from Sanek et al., 2009
arxa chemical treatment: ethanol Fig. 6 with image from Sanek et al., 2008
standard conditions Fig. 4 with image from Sanek et al., 2009
Fig. 1 with imageFig. 4 with image from Sanek et al., 2008
dbx1a standard conditions Fig. 2 with image from Sanek et al., 2008
dlx2a standard conditions Fig. 4 with image from Sanek et al., 2009
Fig. 2 with imageFig. 4 with imageFig. 5 with imageFig. S4 with image from Sanek et al., 2008
emx1 standard conditions Fig. 2 with image from Sanek et al., 2008
eomesa standard conditions Fig. S3 with image from Sanek et al., 2008
fezf2 standard conditions Fig. S1 with image from Sanek et al., 2008
fgf8a standard conditions Fig. 5 with image from Sanek et al., 2009
foxg1a standard conditions Fig. 2 with imageFig. S3 with imageFig. S4 with image from Sanek et al., 2008
gli1 standard conditions Fig. 7 with image from Sanek et al., 2008
gli2a standard conditions Fig. 7 with image from Sanek et al., 2008
gli3 standard conditions Fig. 7 with image from Sanek et al., 2008
irx1b standard conditions Fig. 7 with imageFig. S1 with image from Sanek et al., 2008
isl1a standard conditions Fig. 3 with image from Sanek et al., 2008
lef1 standard conditions Fig. S3 with image from Sanek et al., 2008
lhx1a standard conditions Fig. S3 with image from Sanek et al., 2008
nkx2.1 standard conditions Fig. 2 with image from Sanek et al., 2008
nkx2.2a standard conditions Fig. 7 with image from Sanek et al., 2008
nkx2.4b standard conditions Fig. S3 with image from Sanek et al., 2008
otpb standard conditions Fig. 3 with image from Sanek et al., 2008
oxt standard conditions Fig. 3 with image from Sanek et al., 2008
pax2a standard conditions Fig. 5 with imageFig. 6 with imageFig. 9 with image from Sanek et al., 2009
pax6a standard conditions Fig. 2 with image from Sanek et al., 2008
ptch2 standard conditions Fig. 7 with image from Sanek et al., 2008
rx3 standard conditions Fig. 5 with image from Sanek et al., 2009
Fig. S1 with imageFig. S3 with image from Sanek et al., 2008
shha standard conditions Fig. 2 with imageFig. 7 with imageFig. S4 with image from Sanek et al., 2008
sim1a standard conditions Fig. 3 with image from Sanek et al., 2008
six3b standard conditions Fig. 2 with imageFig. 3 with image from Sanek et al., 2009
Fig. S1 with image from Sanek et al., 2008
vax1 standard conditions Fig. 5 with image from Sanek et al., 2009
Reporter gene expression No data available
PHENOTYPE
Phenotype in AB + MO3-zic2a
Phenotype Conditions Figures
apoptotic process rate, normal standard conditions text only from Sanek et al., 2008
cell proliferation in forebrain disrupted, abnormal chemical treatment: 5-bromo-2'-deoxyuridine Fig. 4 with image from Sanek et al., 2008
cell proliferation in forebrain occurrence, normal chemical treatment: 5-bromo-2'-deoxyuridine Fig. 4 with image from Sanek et al., 2008
diencephalon development disrupted, abnormal standard conditions Fig. 1 with imageFig. 2 with imageFig. 5 with image from Sanek et al., 2008
diencephalon development disrupted, abnormal chemical treatment: ethanol Fig. 6 with image from Sanek et al., 2008
diencephalon development disrupted, abnormal chemical treatment: ethanol, chemical treatment: Cyclopamine Fig. 6 with image from Sanek et al., 2008
negative regulation of DNA-templated transcription disrupted, abnormal standard conditions Fig. 2 with imageFig. 3 with image from Sanek et al., 2009
neurogenesis disrupted, abnormal standard conditions Fig. 3 with image from Sanek et al., 2008
optic fissure closure incomplete, abnormal standard conditions Fig. 6 with image from Sanek et al., 2009
regulation of smoothened signaling pathway disrupted, abnormal standard conditions Fig. 3 with image from Sanek et al., 2009
ventral thalamus decreased size, abnormal standard conditions Fig. 1 with imageFig. 2 with imageFig. S3 with imageFig. S4 with image from Sanek et al., 2008
ventral thalamus decreased size, abnormal chemical treatment: ethanol, chemical treatment: Cyclopamine Fig. 6 with image from Sanek et al., 2008
ventral thalamus decreased size, abnormal chemical treatment: ethanol Fig. 6 with image from Sanek et al., 2008

CITATIONS  (3)